VisionariesArtsey, these guys would likely immediately shut down HH, eliminating all associated costs.
They would concentrate on AH as they should and as quickly as possible turn a profit. They would grow AH and keep HH in the wings probing it's possibilities. Our share price would grow in a sustainable fashion since AH is a constant money maker. If, and when any HH may percolate, they would pursue, hopefully, on a cost benefit basis.
Graeme et al have failed wrt Econiche, Urocidin, VMC, GMP, and most importantly Shareholder Value. Wow!